Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
SINOMAB BIO-B (03681)
- 1.410
- -0.020-1.40%
Not Open May 6 15:58 CST
1.96BMarket Cap-16.79P/E (TTM)
1.450High1.390Low4.06MVolume1.450Open1.430Prev Close5.74MTurnover0.29%Turnover RatioLossP/E (Static)1.39BShares3.76052wk High3.47P/B1.96BFloat Cap1.16052wk Low--Dividend TTM1.39BShs Float7.300Historical High--Dividend LFY4.20%Range %0.800Historical Low1.413Avg Price300Lot Size--Div Yield TTM--Div Yield LFY
SINOMAB BIO-B (03681) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 43.29%-104.99M | ---- | 23.85%-185.14M | ---- | 14.45%-243.11M | ---- | 1.40%-284.16M | ---- | -135.07%-288.19M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 36.86%-3.71M | ---- | 4.78%-5.88M | ---- | 35.55%-6.18M | ---- | 42.73%-9.58M | ---- | 3.55%-16.73M | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | 25.81%5.4M | ---- | 474.16%4.29M | ---- |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | --1.48M | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | --1.48M | ---- | ---- | ---- |
| Revaluation surplus: | -46.98%-729K | ---- | -196.50%-496K | ---- | 52.52%514K | ---- | 125.07%337K | ---- | 95.24%-1.34M | ---- |
| -Other fair value changes | -46.98%-729K | ---- | -196.50%-496K | ---- | 52.52%514K | ---- | 125.07%337K | ---- | 95.24%-1.34M | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | 96.78%-1.24M | ---- | ---38.33M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | --1.44M | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | 96.89%-1.24M | ---- | ---39.77M | ---- | ---- | ---- |
| Depreciation and amortization: | -9.71%27.35M | ---- | -16.02%30.29M | ---- | 28.65%36.06M | ---- | 35.72%28.03M | ---- | 93.53%20.66M | ---- |
| -Amortization of intangible assets | -32.56%845K | ---- | -2.94%1.25M | ---- | 28.84%1.29M | ---- | 199.10%1M | ---- | --335K | ---- |
| Financial expense | -36.20%5.53M | ---- | 31.55%8.66M | ---- | 32.69%6.58M | ---- | -14.76%4.96M | ---- | 140.94%5.82M | ---- |
| Special items | -101.73%-286K | ---- | -12.98%16.53M | ---- | 278.61%19M | ---- | -92.29%5.02M | ---- | 86.43%65.07M | ---- |
| Operating profit before the change of operating capital | 43.52%-76.84M | ---- | 27.78%-136.04M | ---- | 34.33%-188.37M | ---- | -36.31%-286.85M | ---- | -76.16%-210.44M | ---- |
| Change of operating capital | ||||||||||
| Accounts payable increase (decrease) | -353.81%-4.34M | ---- | 113.87%1.71M | ---- | -13.60%-12.31M | ---- | -131.88%-10.84M | ---- | 261.27%34M | ---- |
| prepayments (increase)decrease | 397.28%6.99M | ---- | -103.87%-2.35M | ---- | 587.74%60.66M | ---- | -198.35%-12.44M | ---- | 169.69%12.64M | ---- |
| Cash from business operations | 45.72%-74.19M | ---- | 2.39%-136.68M | ---- | 54.85%-140.02M | ---- | -89.34%-310.12M | ---- | -3.22%-163.79M | ---- |
| Interest received - operating | -36.86%3.71M | ---- | -4.78%5.88M | ---- | -35.55%6.18M | ---- | -42.73%9.58M | ---- | -3.55%16.73M | ---- |
| Special items of business | ---- | 61.88%-26.91M | ---- | -12.49%-70.59M | ---- | 56.90%-62.75M | ---- | -63.84%-145.59M | ---- | -20.20%-88.86M |
| Net cash from operations | 46.12%-70.48M | 61.88%-26.91M | 2.28%-130.8M | -12.49%-70.59M | 55.46%-133.85M | 56.90%-62.75M | -104.36%-300.54M | -63.84%-145.59M | -4.05%-147.06M | -20.20%-88.86M |
| Cash flow from investment activities | ||||||||||
| Decrease in deposits (increase) | 212.50%44.99M | 216.95%44.99M | -699.86%-39.99M | ---38.47M | ---5M | ---- | ---- | ---- | ---- | 96.11%-20.98M |
| Sale of fixed assets | 1,302.86%491K | --459K | 600.00%35K | ---- | --5K | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | 39.21%-25.03M | 53.76%-12.99M | 60.16%-41.17M | 54.13%-28.1M | 8.35%-103.34M | -0.96%-61.25M | 43.12%-112.75M | 10.17%-60.67M | -160.99%-198.23M | -730.23%-67.54M |
| Purchase of intangible assets | 17.17%-275K | -116.67%-65K | 40.07%-332K | 53.13%-30K | 66.01%-554K | 79.68%-64K | 90.23%-1.63M | -7.51%-315K | -1.96%-16.69M | 98.21%-293K |
| Recovery of cash from investments | -49.49%123.49M | -69.12%25.39M | 356.18%244.47M | 311.06%82.21M | -50.80%53.59M | -33.87%20M | -38.48%108.93M | -67.14%30.24M | --177.05M | --92.05M |
| Cash on investment | 50.52%-127.42M | 75.49%-22.55M | -528.05%-257.5M | -360.00%-92M | 45.33%-41M | 71.43%-20M | 25.87%-75M | -5.78%-70M | -16.43%-101.17M | 4.88%-66.17M |
| Other items in the investment business | ---- | ---- | ---- | ---- | 30.79%-625K | 33.72%-625K | -167.19%-903K | -319.30%-943K | --1.34M | --430K |
| Net cash from investment operations | 117.20%16.25M | 146.12%35.23M | 2.52%-94.48M | -23.33%-76.39M | -19.13%-96.92M | 39.09%-61.94M | 40.92%-81.36M | -62.67%-101.69M | 23.17%-137.7M | 90.14%-62.51M |
| Net cash before financing | 75.93%-54.23M | 105.66%8.32M | 2.38%-225.28M | -17.87%-146.98M | 39.57%-230.77M | 49.57%-124.69M | -34.11%-381.9M | -63.36%-247.27M | 11.17%-284.77M | 78.61%-151.37M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -68.99%30.2M | -69.70%27.13M | -21.59%97.37M | 21.14%89.55M | 73.07%124.19M | 154.59%73.92M | -49.93%71.76M | -57.04%29.03M | 256.69%143.32M | 77.09%67.58M |
| Refund | -67.07%-111.6M | -84.63%-84.1M | -187.31%-66.8M | -203.67%-45.55M | -365.00%-23.25M | -500.00%-15M | 0.00%-5M | 0.00%-2.5M | ---5M | ---2.5M |
| Issuing shares | 680.73%428.19M | 91.37%108.24M | 446.37%54.85M | --56.56M | -78.22%10.04M | ---- | --46.09M | ---- | ---- | ---- |
| Interest paid - financing | -8.48%-6.18M | 5.88%-2.64M | 30.76%-5.7M | 13.23%-2.81M | -64.88%-8.23M | -323.01%-3.24M | -6.37%-4.99M | 75.93%-765K | -36.08%-4.69M | -270.83%-3.18M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---59.67M | ---59.67M |
| Net cash from financing operations | 349.57%329.39M | -59.05%38.26M | -10.94%73.27M | 122.26%93.45M | -19.57%82.27M | 101.12%42.04M | 77.84%102.29M | 366.44%20.91M | 405.80%57.52M | 38.77%-7.85M |
| Effect of rate | -240.02%-14.35M | -313.92%-7.45M | 10.49%10.25M | -81.80%3.48M | -84.41%9.28M | -37.78%19.15M | 395.55%59.52M | 480.10%30.77M | 60.62%-20.14M | -149.27%-8.1M |
| Net Cash | 281.01%275.16M | 187.03%46.59M | -2.37%-152.02M | 35.23%-53.53M | 46.89%-148.5M | 63.49%-82.65M | -23.04%-279.61M | -42.18%-226.37M | 33.04%-227.25M | 77.90%-159.21M |
| Begining period cash | -69.61%61.9M | -69.61%61.9M | -40.60%203.66M | -41.09%203.66M | -39.09%342.89M | -38.59%345.71M | -30.53%562.98M | -30.53%562.98M | -32.52%810.37M | -32.52%810.37M |
| Cash at the end | 421.34%322.71M | -34.23%101.03M | -69.61%61.9M | -45.57%153.62M | -40.60%203.66M | -23.18%282.21M | -39.09%342.89M | -42.87%367.39M | -30.53%562.98M | 29.42%643.06M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --146.25M |
| Cash and cash equivalent balance | ---- | -34.23%101.03M | ---- | -46.37%153.62M | ---- | -22.08%286.46M | ---- | -42.83%367.64M | ---- | --643.06M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"